Recombined humanized endostatin (Endostar) intravenous infusion in the treatment of refractory nasopharyngeal carcinoma: Three case reports

RATIONALE: Refractory nasopharyngeal carcinoma is challenging to treat and at present there is no standard treatment or any good choice. PATIENT CONCERNS: Although the three patients in our case reports had already underwent multiple treatments before, they still suffered from disease recurrence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chen, Liu, Song-Ran, Zhou, Shu, Li, Xiao-Hui, Wang, Xiao-Hui, Tao, Ya-Lan, Chang, Hui, Zhang, Wen-Wen, Li, Wen-Fei, Zhou, Si-Lang, Xia, Yun-Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709293/
https://www.ncbi.nlm.nih.gov/pubmed/31393358
http://dx.doi.org/10.1097/MD.0000000000016592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709293/
https://www.ncbi.nlm.nih.gov/pubmed/31393358
http://dx.doi.org/10.1097/MD.0000000000016592

Ejemplares similares